| Issue |
Section |
Title |
File |
| Vol 1, No 1 (2010) |
Articles |
A real way of reducing coronary heart disease mortality in Russia |
(Rus)
|
| Vol 2, No 1 (2011) |
Articles |
Preduprezhdenie serdechno-sosudistykhoslozhneniy u patsientov s faktorami riskas pozitsii dokazatel'noy meditsiny |
(Rus)
|
| Vol 2, No 1 (2011) |
Articles |
Perspektivy klinicheskogo primeneniyanovoy fiksirovannoy kombinatsii -preparata Ko-Eksforzh v lecheniiarterial'noy gipertonii |
(Rus)
|
| Vol 4, No 2 (2013) |
Articles |
Optimization of therapy in a patient with coronary heart disease in clinical practice: proven efficacy of the selective If channel inhibitor ivabradine |
(Rus)
|
| Vol 4, No 1 (2013) |
Articles |
Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial) |
(Rus)
|
| Vol 4, No 1 (2013) |
Articles |
Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects |
(Rus)
|
| Vol 6, No 1 (2015) |
Articles |
Comprehensive medical rehabilitation program after percutaneous coronary intervention for acute myocardial infarction in patients with coronary heart disease and arterial hypertension: efficacy, safety, and the results of remote monitoring |
(Rus)
|
| Vol 6, No 3 (2015) |
Articles |
The clinical efficacy of a comprehensive program of rehabilitation after coronary artery bypass grafting in patients with coronary artery disease under outpatient department cardio rehabilitation - III stage of rehabilitation |
(Rus)
|
| Vol 5, No 3-4 (2014) |
Articles |
ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1) |
(Rus)
|
| Vol 6, No 1 (2015) |
Articles |
The clinical efficacy of a fixed combination of angiotensin receptor blockers valsartan II with a calcium antagonist amlodipine - drug Exforge® smokers patients with cardiovascular disease and chronic obstructive pulmonary disease |
(Rus)
|
| Vol 6, No 3 (2015) |
Articles |
Radiofrequency ablation and antiarrhythmic therapy in the treatment of patients with paroxysmal and persistent atrial fibrillation: clinical effects |
(Rus)
|
| Vol 6, No 3 (2015) |
Articles |
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part II |
(Rus)
|
| Vol 6, No 1 (2015) |
Articles |
Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2) |
(Rus)
|
| Vol 6, No 2 (2015) |
Articles |
Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part I |
(Rus)
|
| Vol 7, No 1 (2016) |
Articles |
Methodic recommendations Maintaining physical activity of those with limitations in health |
(Rus)
|
| Vol 8, No 3 (2017) |
Articles |
Current state and problems of cardio rehabilitation in Russia |
(Rus)
|
| Vol 8, No 3 (2017) |
Articles |
Modern opportunities for lifestyle changes and statin therapy in the prevention of cardiovascular diseases |
(Rus)
|
| Vol 8, No 4 (2017) |
Articles |
High-intensity therapy: rationale, indications and safety issues. Prospects of rosuvastatin in clinical practice |
(Rus)
|
| Vol 8, No 4 (2017) |
Articles |
Basic principles of antiplatelet therapy from the perspective of new recommendations |
(Rus)
|
| Vol 9, No 1 (2018) |
Articles |
Clinical efficacy of pitavastatin |
(Rus)
|
| Vol 9, No 2 (2018) |
Articles |
New tendencies in the treatment of diabetic and cardiovascular diseases: a view of cardiologists |
(Rus)
|
| Vol 10, No 1 (2019) |
Articles |
Adverse effects of statin therapy: real evidence |
(Rus)
|
| Vol 11, No 1 (2020) |
Original study articles |
Modern principles of atherogenic dyslipidemia management in special groups of patients |
(Rus)
|
| Vol 11, No 4 (2020) |
Editorial |
Rehabilitation after new coronavirus infection (COVID-19): principles and approaches |
(Rus)
|
| Vol 12, No 2 (2021) |
Consensus |
Novel сoronavirus infectious disease COVID-19: features of comprehensive cardiac and respiratory rehabilitation |
(Rus)
|
| Vol 12, No 2 (2021) |
Reviews |
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities |
(Rus)
|
| Vol 12, No 4 (2021) |
Reviews |
Type 2 diabetes mellitus and chronic heart failure: new treatment strategies |
(Rus)
|
| Vol 13, No 1 (2022) |
Reviews |
Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review |
(Rus)
|
| Vol 13, No 1 (2022) |
Reviews |
Current guidelines for β-adrenoblockers use in cardiovascular diseases: focus on metoprolol succinate CR/XL: A review |
(Rus)
|
| Vol 14, No 3 (2023) |
Original study articles |
Long-term effects of a home exercise program in patients with acute myocardial infarction and percutaneous coronary intervention: prospective observational study |
(Rus)
|
| Vol 15, No 4 (2024) |
Reviews |
Maintaining optimal physical activity of patients following cardiac rehabilitation |
(Rus)
|
| Vol 16, No 1 (2025) |
Consensus |
The place of original pitavastatin in primary and secondary prevention of cardiovascular diseases. Interdisciplinary Expert Consensus of the Russian Society of Cardiology, the National Atherosclerosis Society, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention, and the Russian Association of Endocrinologists |
(Rus)
|
